In the present study, we demonstrate that CPP has synergistic anti-tumor activity with TRAIL on ESCC cells through upregulating the DR4 and DR5 via a novel mechanism. This evidence concerns the gene TNFRSF10B and esophageal squamous cell carcinoma.